Zentane Systems have developed artificial intelligence to identify antiviral compounds that merit further study as possible pharmaceutical treatments for COVID-19.
Our work aims to discover the underlying associations between amino acid sequences of viral proteins and antiviral agents that are effective against them using the artificial intelligence technology of artificial neural networks (ANN).